Dedra H. Fagan

Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control

Mikhael F. El‐Chami, Faisal Al-Samadi, Nicolas Clementy et al. · Heart Rhythm · 2018 · 333 citations · Full text

Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study

Gábor Zoltán Duray, Philippe Ritter, Mikhael F. El‐Chami et al. · Heart Rhythm · 2017 · 292 citations · Full text

Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation

Hua Zhang, Dedra H. Fagan, Xianke Zeng et al. · Oncogene · 2010 · 122 citations · Full text

Cancer Cell Proliferation, Insulin Receptor Downregulation, Medicine +9

Acquired Resistance to Tamoxifen Is Associated with Loss of the Type I Insulin-like Growth Factor Receptor: Implications for Breast Cancer Treatment

Dedra H. Fagan, Ryan R. Uselman, Deepali Sachdev et al. · Cancer Research · 2012 · 101 citations

Incidence and outcomes of systemic infections in patients with leadless pacemakers: Data from the Micra IDE study

Mikhael F. El‐Chami, Kyoko Soejima, Jonathan P. Piccini et al. · Pacing and Clinical Electrophysiology · 2019 · 85 citations